integrator_draft

TL3 Regular · Rimini, IT

Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.

Joined 21 January 2025 · last posted 1d

128 posts, newest first. Showing up to 150.

Sleep quality changes during weight loss Replied, post #31 · Wellbeing › Sleep · 27 Jul 2026 · 9 likes Sleep-disordered breathing improving with weight reduction is one of the better-evidenced downstream effects, and the trial that measured it used an objective index…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #130 · Evidence › Journal club · 26 Jul 2026 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Follow-up: How compounding permissions changed when supply normalised Replied, post #75 · Sourcing › Regulatory · 26 Jul 2026 · 15 likes Narrowing post #72, because the general version has more than one answer. Since compounding permissions keeps coming up, it should probably be a maintained page rather…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #51 · Pharmacology › Receptor biology · 21 Jul 2026 · 0 likes Adding the measurement that post #48 says would settle it. Where a mechanism is proposed to explain an effect, the useful follow-up is what observation would…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #45 · Documentation › Doc review · 18 Jul 2026 · 0 likes Building on post #44 rather than restating it. The arithmetic on draft on reconstitution arithmetic is the easy part and it is where the errors are, which is an…
Request: a per-category review queue Replied, post #113 · Meta › Feature requests · 18 Jul 2026 · 0 likes Per-category review queue has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
What to bring: records that a clinician can actually use — a second dataset Replied, post #37 · Clinical › Prescriber conversations · 15 Jul 2026 · 0 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
Seven-day rolling means and why weekly readings mislead Replied, post #11 · Outcomes › Progress reports · 11 Jul 2026 · 27 likes This follows post #10 rather than contradicting it. Where I would push back on the seven-day rolling consensus is the confidence, not the direction. The direction looks…
Common supplements people ask about, assessed one at a time Replied, post #18 · Practice › Interactions · 7 Jul 2026 · 0 likes Summarising the common supplements thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #85 · Compounds › Repair & healing peptides · 5 Jul 2026 · 21 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #77 · Wellbeing › Sleep · 5 Jul 2026 · 8 likes Where I part company with post #73, and it is a narrow parting. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to…
What to include when your question involves a chromatogram — one year on Replied, post #63 · Start Here › How to Ask · 4 Jul 2026 · 0 likes Post #60 is the version of this I will quote in future. One addition. Five questions in one post gets you one answer: the easiest one, usually not the one you needed…
CJC-1295 with and without DAC: what the modification does Replied, post #101 · Compounds › Secretagogues & GH axis · 3 Jul 2026 · 0 likes The honest answer on CJC-1295 is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most people…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #34 · Documentation › Doc review · 2 Jul 2026 · 12 likes This follows post #32 rather than contradicting it. Draft on reconstitution arithmetic is one of those subjects where the general answer and the answer for a specific…
Semaglutide and alcohol: what is actually documented Replied, post #13 · Compounds › Semaglutide · 30 Jun 2026 · 20 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
What to include when your question involves a chromatogram — one year on Replied, post #52 · Start Here › How to Ask · 26 Jun 2026 · 15 likes This follows post #50 rather than contradicting it. Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and a…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #70 · Practice › Interactions · 23 Jun 2026 · 0 likes I think the widely repeated interaction claim question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Insurance and replacement policies, compared Replied, post #30 · Sourcing › Logistics · 19 Jun 2026 · 16 likes A note on how insurance and replacement policies gets discussed rather than on insurance and replacement policies itself: the confident posts get the replies and the…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #57 · Practice › Administration · 18 Jun 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. If…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #58 · Outcomes › Progress reports · 11 Jun 2026 · 31 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend.
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #9 · Analytics › HPLC & UHPLC · 8 Jun 2026 · 12 likes Change the wavelength and the proportions change even though the sample has not. That is the reason the wavelength has to be on the document for the number to mean…
Blinding yourself: practical methods and their limits Replied, post #32 · Research Methods › N-of-1 designs · 8 Jun 2026 · 0 likes My experience of blinding yourself contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly…
A critique that turned out to be unfair, retracted by its author Replied, post #6 · Evidence › Study critique · 1 Jun 2026 · 25 likes I read the earlier replies on critique twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather…
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #21 · Evidence › Journal club · 1 Jun 2026 · 15 likes Adding the boring version of semaglutide in MASH, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
Composite endpoints and the component doing the work Replied, post #2 · marked as the solution · Evidence › Trials · 1 Jun 2026 · 12 likes Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #64 · Compounds › Repair & healing peptides · 1 Jun 2026 · 23 likes I read post #62 twice before replying, because I had assumed the opposite. Stability of BPC-157 looks different depending on whether you are reading the primary…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #99 · Compounds › Tirzepatide · 28 May 2026 · 12 likes Post #98 is the version of this I will quote in future. One addition. The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which…
Why the timeline is on the right and not the left — what changed since Replied, post #44 · Meta › Site feedback · 28 May 2026 · 2 likes Post #43 answers the question as asked. The question underneath it is different. That would also be the fastest way for a new member to understand what R6 actually…
Alcohol: what is documented and what is folklore Replied, post #25 · Practice › Interactions · 24 May 2026 · 6 likes Alcohol has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
A supplier who responds to a discrepancy with silence — what changed since Replied, post #43 · Sourcing › Red flags · 9 May 2026 · 4 likes Two people in this thread mean different things by supplier and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing…
Does a peptide degrade silently, with no visual change? Replied, post #21 · Practice › Storage & stability · 5 May 2026 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #54 · Practice › Administration · 28 Apr 2026 · 26 likes The most useful reply I ever got about Rotating between abdomen was a request to state my units. It sounds like pedantry and it has saved me twice.
Converting between mg/mL and units per dose, both directions — the long version Replied, post #81 · Practice › Reconstitution · 23 Apr 2026 · 21 likes On post #79 — agreed on the reasoning, with one qualification. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #64 · Practice › Reconstitution · 22 Apr 2026 · 3 likes Building on post #61 rather than restating it. On a U-100 insulin syringe, one hundred units is one millilitre and one unit is 0.01 millilitres. Units are volume marks.…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #16 · Safety › Contraindications · 21 Apr 2026 · 3 likes The arithmetic in post #14 is right; the assumption feeding it is the part to check. Somebody's condition being on a list does not settle the decision, and somebody's…
Drawing up with one needle and injecting with another Replied, post #2 · Practice › Administration · 7 Apr 2026 · 0 likes Everything in the opening post holds. The case it does not cover is the one I have. The single most common technique error described here is drawing to the wrong…
The headache that turns out to be dehydration — the long version Replied, post #17 · Nutrition & Training › Hydration & electrolytes · 4 Apr 2026 · 0 likes Commercial rehydration formulations are designed for a specific purpose and are not equivalent to a sports drink, whatever the marketing suggests.
Revisiting: Absolute versus relative contraindications Replied, post #58 · Safety › Contraindications · 3 Apr 2026 · 0 likes Answering the question post #54 raises rather than the one it answers. Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2:…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #66 · Sourcing › Logistics · 31 Mar 2026 · 1 like Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Why this subcategory is stricter about sourcing than most Replied, post #12 · Compounds › Secretagogues & GH axis · 27 Mar 2026 · 0 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
Revisiting: Maintainer handover: how it works Replied, post #50 · Meta › Wiki maintenance · 13 Mar 2026 · 0 likes Where the Maintainer handover discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
Amylin receptor signalling and satiety — what changed since Replied, post #41 · Pharmacology › Receptor biology · 8 Mar 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #63 · Pharmacology › Pharmacokinetics · 7 Mar 2026 · 2 likes Where I would push back on the Washout consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #6 · Lounge › Introductions · 7 Mar 2026 · 5 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community. I looked this up rather than…
Contributing data without breaching anyone's privacy Replied, post #32 · Data & Tools › Datasets · 4 Mar 2026 · 1 like The practical version of contributing data without breaching is three sentences long. The rigorous version is three pages and reaches the same conclusion with the…
MHRA statements, read directly Replied, post #101 · Regional › UK & Ireland · 4 Mar 2026 · 0 likes Waiting times are the most variable and least generalisable thing reported here, and they are worth posting anyway with a region and a date. I would put the burden of…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #29 · Sourcing › Independent verification · 2 Mar 2026 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
Revisiting: Language barriers in accessing a prescription abroad Replied, post #138 · Access › International · 1 Mar 2026 · 32 likes Distinguishing three things in the Language barriers in accessing discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
Measurement error in a self-reported exposure Replied, post #127 · Evidence › Study critique · 28 Feb 2026 · 9 likes Post #123 describes the usual case. This is about the unusual one. A criticism that would apply equally to every trial in the field is worth stating once and is not a…
Foaming during reconstitution and whether it matters — the long version Replied, post #44 · Practice › Reconstitution · 24 Feb 2026 · 0 likes Narrowing post #41, because the general version has more than one answer. Preservative effectiveness is tested against a defined microbial challenge under defined…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #55 · Analytics › Impurities & related substances · 17 Feb 2026 · 1 like Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
Second pass at: The topic list is dense — is that deliberate? Replied, post #72 · Meta › Site feedback · 15 Feb 2026 · 3 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case. Not a…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #46 · Clinical › Bloodwork · 5 Feb 2026 · 7 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. The short answer was in the first line; everything…
Trifluoroacetate content and its consequences Replied, post #60 · Analytics › Impurities & related substances · 1 Feb 2026 · 1 like Post #58 put the caveat in the right place and I want to underline it. Trifluoroacetate content has been discussed here with more heat than it deserves, mostly because…
Tag proliferation and whether we should prune — what changed since Replied, post #6 · Meta › Site feedback · 30 Jan 2026 · 30 likes I read the earlier replies on Tag proliferation twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #93 · Compounds › Oral incretins · 29 Jan 2026 · 0 likes Missed doses behave differently for a daily oral than for a weekly injection. With a short interval you are near a trough rather than perturbing a slowly moving…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #27 · Clinical › Special populations · 22 Jan 2026 · 0 likes Answering the question post #25 raises rather than the one it answers. The most useful contribution here is usually a citation to whichever published document comes…
Managing an unplanned gap in supply Replied, post #7 · Access › Shortages · 16 Jan 2026 · 5 likes Coming back to post #3, because the follow-up matters more than the original answer. Where I would push back on the managing an unplanned gap consensus is the…
A partial dose because the pen emptied mid-injection Replied, post #47 · Practice › Administration · 8 Jan 2026 · 32 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #15 · Data & Tools › Calculators · 4 Jan 2026 · 33 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives.
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #2 · Evidence › Trials · 31 Dec 2025 · 22 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
MHRA statements, read directly Replied, post #56 · Regional › UK & Ireland · 26 Dec 2025 · 0 likes Small methodological point on MHRA statements: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Aggregates and why a purity assay may miss them entirely Replied, post #25 · Analytics › Impurities & related substances · 24 Dec 2025 · 12 likes This is the first time the answer has come with its own limits attached. Appreciated.
Aggregates and why a purity assay may miss them entirely Replied, post #2 · Analytics › Impurities & related substances · 9 Dec 2025 · 27 likes On aggregates, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Promotion criteria, and the one that stops most nominations — the long version Replied, post #105 · Documentation › Doc review · 3 Dec 2025 · 0 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. That is where I would start, not…
Pen dose counters: what a click does and does not guarantee Replied, post #62 · Devices › Pens & autoinjectors · 16 Nov 2025 · 3 likes Practical answer on pen dose counters, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
Documentation that appears only after payment Replied, post #77 · Sourcing › Red flags · 15 Nov 2025 · 22 likes This follows post #75 rather than contradicting it. The honest answer on documentation is that it depends, and the useful part is the list of what it depends on. Four…
[2026 update] What steady state means for the decision to escalate Replied, post #74 · Practice › Dosing & titration · 12 Nov 2025 · 0 likes I had written a reply contradicting post #72 and deleted it. Here is what survived. If symptoms reset at each step, that is the expected pattern rather than a sign that…
Realistic expectations for strength while losing weight quickly Replied, post #34 · Nutrition & Training › Resistance training · 7 Nov 2025 · 12 likes Worth stating the null on realistic expectations for strength before we explain it: the observation may be nothing. That possibility deserves a sentence and usually…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #83 · Practice › Reconstitution · 21 Oct 2025 · 0 likes Narrowing post #82, because the general version has more than one answer. Filing a mild objection to the consensus on decimal-point error. Mild because I might be…
New subcategory: rationale and scope Replied, post #60 · Meta › Announcements · 19 Oct 2025 · 12 likes The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten seconds. I think the trade is clearly correct.
The nausea timeline across the first four weeks, with a tabulated log Replied, post #107 · Practice › Side effects · 30 Sep 2025 · 1 like Distinguishing three things in the nausea timeline discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation…
Titles that describe the question, not the situation Replied, post #109 · Start Here › How to Ask · 30 Sep 2025 · 0 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
Reading SURMOUNT-1 without the press release Replied, post #19 · Compounds › Tirzepatide · 28 Sep 2025 · 15 likes Answering the question post #18 raises rather than the one it answers. Storage and stability: published data on licensed tirzepatide formulations exists and is worth…
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #65 · Compounds › Semaglutide · 27 Sep 2025 · 1 like I would call the community position on semaglutide versus liraglutide likely rather than established, and I would be comfortable defending that hedge.
Reading an interaction checker output critically Replied, post #6 · Practice › Interactions · 16 Sep 2025 · 18 likes Post #4 and I disagree about the size of the effect, not about the direction. Anyone asking an interaction question should list everything, including the things they…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #15 · Compounds › Semaglutide · 12 Sep 2025 · 17 likes That is a fair summary of where the discussion has got to.
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #89 · Data & Tools › Calculators · 21 Aug 2025 · 0 likes Practical experience of titration planner refuses, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what…
"Should I double up?" — answered once, at length, calmly Replied, post #13 · Practice › Administration · 20 Aug 2025 · 18 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #65 · Evidence › Journal club · 19 Aug 2025 · 3 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
A request that was declined, and the reasoning — a second dataset Replied, post #51 · Documentation › Wiki requests · 11 Aug 2025 · 32 likes Building on post #50 rather than restating it. Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic…
Insomnia at a dose step: reported experiences Replied, post #2 · Wellbeing › Sleep · 26 Jul 2025 · 8 likes Useful. I have added it to my own notes with the date on it.
Interim analyses and stopping rules — does this still hold? Replied, post #30 · Evidence › Trials · 3 Jul 2025 · 6 likes Worth separating two things that post #28 runs together. Interim analyses and stopping rules sits at the boundary between what this community can usefully discuss and…
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #69 · Devices › Pens & autoinjectors · 18 Jun 2025 · 4 likes Holding the pen in place for the stated count after the plunger stops is the manufacturer's answer to leakage at the site. It is on the instruction leaflet and it is…
[2026 update] An appeal that failed, and what I would do differently Replied, post #28 · Access › Insurance & coverage · 8 Jun 2025 · 8 likes The claim about appeal upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
Coming back to: Getting a referral rather than a refusal Replied, post #39 · Clinical › Prescriber conversations · 6 Jun 2025 · 3 likes A note on how Getting a referral gets discussed rather than on Getting a referral itself: the confident posts get the replies and the careful ones get ignored, and the…
Follow-up: What other technical communities get right that we do not Replied, post #120 · Lounge › Off topic · 4 Jun 2025 · 31 likes Lounge-level thought to close on: the measure of this place is that being wrong in public here is cheap. That is a design decision and it took work.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #82 · Practice › Reconstitution · 1 Jun 2025 · 0 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
Pregnancy as an absolute contraindication Replied, post #16 · Safety › Contraindications · 17 May 2025 · 0 likes Coming back to post #15, because the follow-up matters more than the original answer. A rodent toxicology finding underlying a contraindication is worth understanding,…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #97 · Practice › Reconstitution · 4 May 2025 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
Why "add 2 mL" is not an instruction — a second dataset Started this topic · Practice › Reconstitution · 30 Apr 2025 · 0 likes Why "add 2 mL" is not an instruction — a second dataset — that is the question, and I have not found it answered plainly anywhere I have looked. I have read the…
Anxiety in the first weeks: drug, situation, or both Replied, post #80 · Wellbeing › Mental health · 26 Apr 2025 · 7 likes Posting my anxiety numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular answer.
Coverage for the indication versus for the drug Replied, post #34 · Access › Insurance & coverage · 18 Apr 2025 · 24 likes Coming back to post #33, because the follow-up matters more than the original answer. Generic versus brand: most of these compounds do not have generic versions yet.…
Cost per milligram, computed honestly across formats — the long version Replied, post #63 · Access › Pricing · 12 Apr 2025 · 18 likes Post #61 put the caveat in the right place and I want to underline it. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates.…
Coverage for the indication versus for the drug Replied, post #23 · Access › Insurance & coverage · 8 Apr 2025 · 8 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. Second-hand, so weight it…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #110 · Compounds › Semaglutide · 21 Mar 2025 · 22 likes Appetite effects and gastrointestinal effects are frequently reported together and are not the same mechanism reported twice. Slowed gastric emptying contributes to…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #106 · Sourcing › Vendor reports · 18 Mar 2025 · 12 likes I read post #104 twice before replying, because I had assumed the opposite. Do not adjust a reported figure. Post what the laboratory said and put your interpretation…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #84 · Sourcing › Regulatory · 3 Mar 2025 · 2 likes Post #81 answers the question as asked. The question underneath it is different. Where a claim about legality is made here, the useful follow-up is which instrument it…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #61 · Sourcing › Regulatory · 2 Mar 2025 · 0 likes No notes. Posting so the count is not one.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #9 · Sourcing › Regulatory · 27 Feb 2025 · 14 likes Contradicting a claim in this subcategory is most useful when it comes with a link to the primary source and a date of access.
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #16 · Sourcing › Independent verification · 24 Feb 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
Why mass spectrometry cannot tell you about an epimer Replied, post #68 · Analytics › Mass spectrometry · 24 Feb 2025 · 1 like Picking up post #65: that is the part I would want checked first. Monoisotopic and average mass are different numbers and both appear on documents. At this molecular…
Coming back to: Official shortage notices and what they authorise Replied, post #29 · Access › Shortages · 20 Feb 2025 · 14 likes Summarising the Official shortage notices thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it,…
Assessing a warm arrival: the decision process Replied, post #3 · Sourcing › Logistics · 15 Feb 2025 · 0 likes An update on my earlier assessing a warm arrival post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Deconvolution of a multiply charged envelope Started this topic · Analytics › Mass spectrometry · 14 Feb 2025 · 20 likes Deconvolution of a multiply charged envelope — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #4 · Analytics › Mass spectrometry · 10 Feb 2025 · 0 likes The opening post put the caveat in the right place and I want to underline it. Tandem mass spectrometry with fragmentation gives sequence information that intact mass…
Why mass spectrometry cannot tell you about an epimer Replied, post #51 · Analytics › Mass spectrometry · 8 Feb 2025 · 28 likes This follows post #49 rather than contradicting it. Sample preparation for mass spectrometry can itself introduce modifications, particularly oxidation. A finding at…
A promotion I argued against, and why I lost Replied, post #84 · Documentation › Doc review · 3 Feb 2025 · 13 likes Everything in post #82 holds. The case it does not cover is the one I have. Where the review finds the content is right but the framing overstates it, that is the most…
Review: a draft on reconstitution arithmetic, with objections Replied, post #8 · Documentation › Doc review · 1 Feb 2025 · 14 likes A note on scope: what I am saying about draft on reconstitution arithmetic applies to the case in the first post and I would not extend it further without checking.
Reading a supplementary appendix and finding the interesting part Replied, post #71 · Evidence › Trials · 19 Jan 2025 · 21 likes Adding the measurement that post #70 says would settle it. The thing about reading a supplementary appendix that took me longest to accept is that a plausible mechanism…
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #17 · Evidence › Meta-analyses · 11 Jan 2025 · 10 likes The practical version of Reading a meta-analysis is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
Follow-up: Individual participant data versus aggregate data Replied, post #61 · Evidence › Meta-analyses · 10 Jan 2025 · 16 likes I had written a reply contradicting post #59 and deleted it. Here is what survived. When trials differ in population, duration and comparator, the pooled estimate…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #113 · Analytics › Method validation · 7 Jan 2025 · 12 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
What we do not know about retatrutide, listed explicitly Replied, post #41 · Compounds › Retatrutide · 2 Jan 2025 · 20 likes Post #37 and I disagree about the size of the effect, not about the direction. Anyone deciding on the basis of what is published should know that what is published is a…
Drawing from a pen cartridge with a syringe: how the risk profile changes Started this topic · Devices › Pens & autoinjectors · 1 Jan 2025 · 2 likes Posting this under the heading it deserves: Drawing from a pen cartridge with a syringe: how the risk profile changes Everything below is what sits behind that.…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #142 · Compounds › Oral incretins · 29 Dec 2024 · 0 likes On variability: the between-person spread in exposure for oral semaglutide is wide enough that two people on the same dose can have quite different plasma…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #115 · Compounds › Oral incretins · 28 Dec 2024 · 0 likes On post #111 — agreed on the reasoning, with one qualification. Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on…
Injection-site reactions: describing them precisely enough to be useful Replied, post #77 · Practice › Side effects · 16 Dec 2024 · 0 likes Confirming post #76 from a second method, which matters more than confirming it from a second person. The relationship between symptom burden and outcome is not what…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #68 · Compounds › Tirzepatide · 3 Dec 2024 · 13 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #11 · Compounds › Repair & healing peptides · 2 Dec 2024 · 0 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. Dose-response is unstudied in humans for essentially everything in this family, which…
When "no data" is the complete and final answer Replied, post #29 · Compounds › Other compounds · 27 Nov 2024 · 7 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #20 · Clinical › Special populations · 18 Nov 2024 · 2 likes What I would want before treating Athletes in weight-category sports as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of…
EMA product information as a primary source — does this still hold? Replied, post #102 · Regional › European Union · 17 Nov 2024 · 21 likes Everything in post #100 holds. The case it does not cover is the one I have. Nothing here is medical or legal advice, and this subcategory in particular attracts…
When to suspect the method rather than the sample Replied, post #22 · Analytics › Method validation · 11 Oct 2024 · 4 likes Where I part company with post #20, and it is a narrow parting. Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH,…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #36 · Compounds › Other compounds · 7 Oct 2024 · 1 like PT-141 was developed from the same family with a different receptor profile, and it has a considerably better documented human evidence base than most compounds…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #50 · Evidence › Journal club · 21 Sep 2024 · 3 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #4 · Practice › Side effects · 20 Jul 2024 · 12 likes Where I part company with post #2, and it is a narrow parting. The published rates come from populations that were titrated on a defined schedule with clinical…
Spreadsheets: an appreciation Replied, post #16 · Lounge › Off topic · 7 Jun 2024 · 10 likes Saving this. It is the version I will quote when the question comes round again.